BCM
ONC

Bayesian Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Bayesian Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,791
Closed -$331K – 1028
2024
Q4 		$331K Buy
+1,791
New +$366K 0.04% 465
2023
Q2 		– Sell
-1,125
Closed -$242K – 1107
2023
Q1 		$242K Buy
+1,125
New +$270K 0.03% 565

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Bayesian Capital Management's ONC Position: Q1 2025 in Review

Bayesian Capital Management sold out of BeOne Medicines Ltd (ONC) in Q1 2025, closing a stake of 1,791 shares — an estimated $331K sold.

Bayesian Capital Management first reported a position in ONC in Q1 2023 and held it in 2 quarters. The position peaked at $331K in Q4 2024. 267 funds tracked by Wall St. Rank hold ONC as of Q1 2025.

  • Bayesian Capital Management reported no remaining BeOne Medicines Ltd position as of Q1 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 1,791 BeOne Medicines Ltd shares in Q1 2025, an estimated $331K.
  • Bayesian Capital Management first reported a position in BeOne Medicines Ltd in Q1 2023 and held it in 2 quarters.
  • Bayesian Capital Management's BeOne Medicines Ltd position peaked at $331K in Q4 2024.
  • 267 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.